JNJ
Johnson & Johnson Pharmaceuticals Bullish Trend flatWhy this read
-
Composite+24 +mild|composite|
-
OI bias38% calls -12pp10,383 total
-
Vol bias77% calls +bullish1,816 vol
-
Stability0.87 +stable7d rolling
-
Confidence66 medqual 72
-
Composite Δ-1 flatvs prior tick
Price vs tape value
Circles mark divergence — where tape and price moved in opposite directions.
Options data
Public delayed tape used for the composite score · source: nasdaq.
⚠ Near-dated expiry in the mix — OI can be noisier close to expiration.
Dealer gamma exposure
What market makers are structurally likely to do about the current options positioning — not what already traded, but what dealers are on the hook to hedge as price moves. Positive GEX tends to dampen volatility (dealers sell rallies, buy dips); negative GEX tends to amplify it. Real strikes and greeks via Massive, computed on demand.
Money flow
Inst 47 · Retail/opt 77 · mixed
Updated 2026-08-26 04:38:27
Earnings backtest
No earnings backtest yet. The cron will populate this once JNJ has enough reported quarters.
Fundamentals & ownership
Recent history
200 points (14d) · 2721 total on record · tape Δ -0.9